News Results
There are 989,865 News Results
Apr 1, 2019
WALTHAM, Mass., April 1, 2019 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today...
Apr 8, 2019
SEATTLE, April 8, 2019 /PRNewswire/ -- Suplari , the AI-powered intelligent spend management system for enterprise procurement and finance, today unveiled a new program to build Custom Insights Applications for...
Apr 11, 2019
Westwater Resources, Inc. (“Westwater,” or the “Company”) (Nasdaq: WWR), an energy materials development company, is pleased to provide the independent test results from long-term cycling data conducted on uncoated, spherical...
Apr 11, 2019
SILVER SPRING, Md., April 11, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today issued a safety labeling change order to Sprout Pharmaceuticals for their drug, Addyi (flibanserin), that...
Apr 12, 2019
WASHINGTON, April 12, 2019 /PRNewswire/ -- Results from NASA's landmark Twins Study, which took place from 2015-2016, were published Thursday in Science. The integrated paper -- encompassing work from 10...
Apr 16, 2019
SAN DIEGO, April 16, 2019 /PRNewswire-PRWeb/ -- Some of the world's leading scientists will be recognized for their research on birth defects, including potential environmental causes, risk factors for deformities...
Apr 16, 2019
SANTA MONICA, Calif., April 16, 2019 /PRNewswire/ -- According to
Apr 16, 2019
MARKHAM, Ontario, April 16, 2019 /PRNewswire-PRWeb/ -- Glen Eyrie Castle & Conference Center's parent company, The Navigators®, purchased the property in 1953 to be its global headquarters. Since then Glen...
Apr 17, 2019
TORRANCE, Calif., April 17, 2019 /PRNewswire/ -- In front of a packed studio audience consisting of top HBCU students, school presidents, HCASC alumni and Honda associates, Spelman College took home...
Apr 18, 2019
-- SKYRIZI(TM)(risankizumab) is a novel, humanized immunoglobulin monoclonal antibody designed to selectively inhibit IL-23 by binding to its p19 subunit to treat moderate to severe plaque psoriasis(1) . IL-23 is...
